ASPERGILLOSIS
Clinical trials for ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cresemba under the microscope: Real-World safety check for fungal infections
Disease control CompletedThis study looked at how safe and effective the drug Cresemba (isavuconazole) is for Korean patients with serious fungal infections like invasive aspergillosis or mucormycosis. Researchers tracked side effects and how well the drug worked in 94 adults. The goal was to confirm the…
Matched conditions: ASPERGILLOSIS
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Hidden fungal threat in COVID-19 ICU patients revealed
Knowledge-focused CompletedThis study monitored 219 adults with severe COVID-19 who needed a ventilator for at least 72 hours. Researchers checked for serious fungal infections, especially aspergillosis, using standard diagnostic methods. The goal was to learn how common these infections are and what puts …
Matched conditions: ASPERGILLOSIS
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to perfect antifungal dosing for sickest ICU patients
Knowledge-focused CompletedThis study looked at 32 adults in the ICU on ECMO life support who had severe influenza or COVID-19 and a serious fungal lung infection called aspergillosis. Researchers measured how the antifungal drug voriconazole behaves in the body to find the best dose for these very ill pat…
Matched conditions: ASPERGILLOSIS
Sponsor: University Hospitals, Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC